Please try another search
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| BIONc1:NS | NSE | INR | Delayed | |
| BION | NSE | INR | Real-time | |
| BIONc2:NS | NSE | INR | Delayed | |
| BIONc3:NS | NSE | INR | Delayed | |
| BION | BSE | INR | Delayed |
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Buy | Buy | Buy |
| Technical Indicators | BUY | Strong Buy | BUY | Strong Buy | Strong Buy |
| Summary | Buy | Strong Buy | Buy | Strong Buy | Strong Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Emerging Patterns | |||||
| Harami Bullish | 1M | Current | |||
| Completed Patterns | |||||
| Three Inside Up | 30 | 3 | Jul 06, 2026 16:00 | ||
| Three Black Crows | 1H | 4 | Jul 06, 2026 13:00 | ||
| Engulfing Bearish | 1W | 5 | May 31, 2026 | ||
| Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| NSE | 425.25 | 424.75 | 425.30 | 8,172,500 | -1.00% | INR | 06/07 | ||
| NSE | 424.30 | 423.00 | 424.30 | 3,802,294 | -0.59% | INR | 06/07 | ||
| NSE | 427.60 | 426.60 | 427.90 | 345,000 | -1.02% | INR | 06/07 | ||
| NSE | 429.85 | 428.95 | 430.35 | 62,500 | -0.91% | INR | 06/07 | ||
| BSE | 424.65 | 421.00 | 424.50 | 101,460 | -0.38% | INR | 06/07 |
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| Jollibee Foods | 149.00 | 150.70 | 144.00 | +3.20 | +2.19% | 1.83M | 06/07 | ||
| PLDT | 1,161.00 | 1,184.00 | 1,161.00 | -10.00 | -0.85% | 74.76K | 06/07 | ||
| Ayala Land | 15.920 | 15.920 | 15.360 | +0.480 | +3.11% | 14.63M | 06/07 | ||
| Apex Mining | 12.9200 | 13.3000 | 12.7200 | +0.0200 | +0.16% | 4.17M | 06/07 | ||
| Bank of the Philippine Islands | 104.00 | 105.10 | 101.00 | +3.00 | +2.97% | 4.17M | 06/07 | ||
| BDO Unibank | 127.00 | 128.50 | 124.50 | +3.50 | +2.83% | 4.19M | 06/07 | ||
| OceanaGold | 33.50 | 34.10 | 32.85 | +0.70 | +2.13% | 443.40K | 06/07 | ||
| ABS CBN | 4.000 | 4.190 | 3.240 | +0.740 | +22.70% | 5.16M | 06/07 | ||
| Synergy Grid | 26.90 | 27.85 | 26.50 | -0.95 | -3.41% | 4.04M | 06/07 | ||
| International Container | 894.500 | 918.000 | 894.500 | -18.500 | -2.03% | 676.78K | 06/07 |
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services, and other research and development in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review